Two Simple Tests May Help PCPs Identify Fibromyalgia

November 01, 2017

"These results suggest that two tests, taking less than one minute, can indicate a probable diagnosis of FM," write the authors.

Clinicians Increasingly Prescribing Gabapentinoids to Avoid Opioids

August 03, 2017

Gabapentinoids are increasingly being used for almost any type of pain. U.S. prescribing data support this, with gabapentin being the 10th most commonly prescribed medication in 2016.

New Method of Pain Control Beneficial in Fibromyalgia

May 01, 2017

10-minute cold application on the trapezius muscle tied to significant decrease in pain score

Fibromyalgia Combo Tx Linked to Better Adherence

April 28, 2017

However, combination prescription initiation also tied to higher health care costs

Diabetic Peripheral Neuropathy Treatments Explored

March 27, 2017

The researchers identified an additional 24 published studies and 25 unpublished studies, since the last completed systematic review of 57 eligible studies.

Gabapentinoid Abuse and Misuse on the Rise

By February 03, 2017

Growing number of patients self-administering higher than recommended doses.

ADA: Updated Diabetic Neuropathy Treatment Guidelines Available

By January 31, 2017

This serves as an update to the last statement released by the ADA in 2005

Do Concomitant Neuropathic Pain Meds Impact Pregabalin Efficacy?

By January 11, 2017

The therapeutic efficacy of pregabalin in treating two types neuropathic pain (NeP) is not influenced by concomitant NeP medications, according to new research published in the journal Pain Physician.

Coenzyme Q10 May Improve Fibromyalgia Symptoms

January 06, 2017

For patients with fibromyalgia (FM), coenzyme Q10 (CoQ10) supplementation is associated with improvement in clinical symptoms, according to a letter to the editor published online in CNS Neuroscience & Therapeutics.

Fibromyalgia Linked to High Prevalence of Anti-TSH Receptor Antibody

December 12, 2016

Patients with fibromyalgia syndrome (FMS) have high prevalence of anti-thyroid-stimulating hormone (TSH) receptor antibody (TRAb), according to a study published in the International Journal of Rheumatic Diseases.

Significant Seizure Reduction with Pregabalin in Pediatric Study

By December 01, 2016

Pfizer announced positive Phase 3 study data that evaluated Lyrica (pregabalin) capsules and oral solution as adjunctive therapy for pediatric epilepsy patients aged 4-16 years with partial onset seizures.

Sublingual Cyclobenzaprine Evaluated in Fibromyalgia Study

By September 06, 2016

Tonix Pharmaceuticals announced preliminary data from the Phase 3 AFFIRM study evaluating TNX-102 SL (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia.

Study Examines Impact of Self-Regulatory Fatigue in Fibromyalgia Patients

September 06, 2016

Patients with fibromyalgia syndrome (FMS) with higher self-regulatory fatigue (SRF) have lower quality of life (QoL), according to a study published online in Pain Practice.

Aquatic Ai Chi Program May Benefit in Fibromyalgia

August 11, 2016

Improvements in almost all variables under study, including pain perception, vitality, mental health

EULAR: Updated Fibromyalgia Management Recommendations

By July 08, 2016

The European League Against Rheumatism (EULAR) has published updated recommendations on the management of fibromyalgia in the Annals of the Rheumatic Diseases.

IV Lidocaine, Amitriptyline Combo Evaluated in Fibromyalgia

June 20, 2016

No clinical manifestations for combination of lidocaine for four weeks with amitriptyline

Are Antipsychotics Beneficial for Fibromyalgia Patients?

By June 06, 2016

Treatment with quetiapine may be considered for a limited duration (4-12 weeks) to reduce pain, sleep problems, depression, and anxiety in fibromyalgia patients with major depression, data from a Cochrane review has shown.

Does Pregabalin Use During Pregnancy Up Birth Defect Risk?

By May 18, 2016

Pregabalin, a drug often used for anxiety, pain, and other neurologic disorders, may be linked to a higher risk of major birth defects, researchers reported in a Neurology study.

Study Shows Combo May Benefit Patients With Fibromyalgia

By March 17, 2016

A combination of the anticonvulsant pregabalin and the antidepressant duloxetine may help improve pain relief, physical function, and overall quality of life in patients with fibromyalgia.

Pregabalin-Antidepressant Combos Examined in Fibromyalgia Study

By February 19, 2016

Combining pregabalin and paroxetine can increase tolerability and reduce depressive symptoms associated with fibromyalgia, a new controlled, randomized study has suggested.

APS: New Clinical Guideline for Post-Surgery Pain Management

February 17, 2016

A new guideline to help clinicians provide optimal pain management for patients following surgery has been released by The American Pain Society.

Acupuncture for Fibromyalgia: Is It Effective?

February 16, 2016

Greater decrease in pain intensity with individualized versus sham acupuncture; effect persisted at 1 year

How Effective Are Opioids in Neuropathic Pain?

By January 25, 2016

A new study suggests that opioid prescriptions for patients with neuropathic pain (NeP) may not improve their physical function or disability.

More Sedentary Time for Females With Fibromyalgia

November 02, 2015

Less time spent engaged in light, moderate, and moderate-to-vigorous physical activity

Opioid Prescriptions Common With Fibromyalgia

October 20, 2015

Opioid use is widespread among patients with newly diagnosed fibromyalgia, and patients taking opioids have a decreased likelihood of receiving guideline-recommended medications.

An Overview of Fibromyalgia in 55 Minutes

September 09, 2015

Use both nonpharmacologic and pharmacologic therapies to address increased distress, decreased activity, isolation, poor sleep, and maladaptive illness behaviors.

Some Patients in Pain More Complicated to Treat Than Others

September 09, 2015

Patient-specific treatment is best for patients who may be at risk of abusing their medication or those with physical complications.

Lupin Launches New Generic Cymbalta Strength

September 03, 2015

Lupin announced the launch of Duloxetine 40mg Delayed-Release (DR) Capsules, the generic version of Eli Lilly's Cymbalta.

How Many Adults Are in Pain? NIH Study Offers Estimates

By August 13, 2015

Research in The Journal of Pain has found that many American adults have recently experienced some level of pain, ranging from brief to chronic and from relatively minor to more severe.

Can Alcohol Reduce Disability in Chronic Pain?

July 31, 2015

Moderate to heavy drinking might cut the likelihood of disability for people with chronic widespread pain such as that related to fibromyalgia.